Health related quality of life associated with extreme obesity in adolescents - results from the baseline evaluation of the YES-study.


Journal

Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626

Informations de publication

Date de publication:
05 Mar 2020
Historique:
received: 17 06 2019
accepted: 26 02 2020
entrez: 7 3 2020
pubmed: 7 3 2020
medline: 4 7 2020
Statut: epublish

Résumé

Obesity can significantly reduce health-related quality of life (HRQoL) and may lead to numerous health problems even in youths. This study aimed to investigate whether HRQoL varies among youths with obesity depending on grade of obesity and other factors. For the Youths with Extreme obesity Study (YES) (2012-2014), a prospective multicenter cohort study, a baseline sample of 431 obese and extremely obese adolescents and young adults (age 14 to 24 years, BMI ≥30 kg/m Three hundred fifty-two adolescents (mean age: 16.6 (±2.4), mean BMI: 39.1 (±7.5) kg/ m HRQoL of adolescents with obesity is reduced, but HRQoL of adolescents with extreme obesity is particularly affected. Larger and longitudinal studies are necessary to understand the relation of extreme obesity and HRQoL, and the impact of other lifestyle or socioeconomic factors. Clinicaltrials.gov NCT01625325; German Clinical Trials Register (DRKS) DRKS00004172.

Sections du résumé

BACKGROUND BACKGROUND
Obesity can significantly reduce health-related quality of life (HRQoL) and may lead to numerous health problems even in youths. This study aimed to investigate whether HRQoL varies among youths with obesity depending on grade of obesity and other factors.
METHODS METHODS
For the Youths with Extreme obesity Study (YES) (2012-2014), a prospective multicenter cohort study, a baseline sample of 431 obese and extremely obese adolescents and young adults (age 14 to 24 years, BMI ≥30 kg/m
RESULTS RESULTS
Three hundred fifty-two adolescents (mean age: 16.6 (±2.4), mean BMI: 39.1 (±7.5) kg/ m
CONCLUSION CONCLUSIONS
HRQoL of adolescents with obesity is reduced, but HRQoL of adolescents with extreme obesity is particularly affected. Larger and longitudinal studies are necessary to understand the relation of extreme obesity and HRQoL, and the impact of other lifestyle or socioeconomic factors.
TRIAL REGISTRATION BACKGROUND
Clinicaltrials.gov NCT01625325; German Clinical Trials Register (DRKS) DRKS00004172.

Identifiants

pubmed: 32138734
doi: 10.1186/s12955-020-01309-z
pii: 10.1186/s12955-020-01309-z
pmc: PMC7059717
doi:

Banques de données

ClinicalTrials.gov
['NCT01625325']

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

58

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : FKZ 01GI1120A
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GI1127
Organisme : Bundesministerium für Bildung und Forschung
ID : FKZ 01GI1401

Références

Pediatrics. 2005 Feb;115(2):340-7
pubmed: 15687442
Surg Endosc. 2012 Nov;26(11):3077-81
pubmed: 22580883
BMC Public Health. 2013 Aug 29;13:789
pubmed: 23987123
Prev Med. 2007 Dec;45(6):401-15
pubmed: 17707498
Eur J Public Health. 2013 Feb;23(1):45-9
pubmed: 22434205
Health Qual Life Outcomes. 2014 Apr 25;12:58
pubmed: 24761773
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Int J Obes (Lond). 2019 Jan;43(1):103-115
pubmed: 30368525
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
pubmed: 15286277
Qual Life Res. 2007 Jun;16(5):881-93
pubmed: 17404899
Qual Life Res. 2014 May;23(4):1117-39
pubmed: 24249217
PLoS One. 2013 Jun 12;8(6):e65764
pubmed: 23776541
Arch Dis Child. 2003 Sep;88(9):748-52
pubmed: 12937090
Obes Surg. 2015 Nov;25(11):2135-42
pubmed: 25898940
Am J Clin Nutr. 2002 Nov;76(5):935-41
pubmed: 12399263
Int J Obes (Lond). 2007 Jan;31(1):39-44
pubmed: 16733522
J Public Health (Oxf). 2005 Jun;27(2):156-64
pubmed: 15820993
Med Care. 1989 Mar;27(3 Suppl):S217-32
pubmed: 2646490
Health Qual Life Outcomes. 2012 Feb 02;10:19
pubmed: 22300248
JAMA. 2003 Apr 9;289(14):1813-9
pubmed: 12684360
Int J Obes Relat Metab Disord. 2000 Dec;24(12):1707-14
pubmed: 11126229
N Engl J Med. 2016 Jun 23;374(25):2430-40
pubmed: 27074389
PLoS One. 2017 Dec 18;12(12):e0189190
pubmed: 29252996
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
Int J Pediatr Obes. 2011 Oct;6(5-6):434-41
pubmed: 21774577
Value Health. 2011 Dec;14(8):1117-29
pubmed: 22152182
Circulation. 2013 Oct 8;128(15):1689-712
pubmed: 24016455
Qual Life Res. 2012 Nov;21(9):1587-94
pubmed: 22161746
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
Health Qual Life Outcomes. 2005 Nov 13;3:70
pubmed: 16283947
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 May-Jun;50(5-6):810-8
pubmed: 17514467
Health Qual Life Outcomes. 2010 Apr 07;8:36
pubmed: 20374656
Soz Praventivmed. 2005;50(5):281-91
pubmed: 16300172
Surg Obes Relat Dis. 2018 Jul;14(7):882-901
pubmed: 30077361
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897

Auteurs

J Felix (J)

Institute of Health Economics and Health Care Management, Helmholtz Zentrum München - German Research Center for Environmental Health, Ingolstaedter Landstrasse 1, Munich, 85764, Neuherberg, Germany.

R Stark (R)

Institute of Health Economics and Health Care Management, Helmholtz Zentrum München - German Research Center for Environmental Health, Ingolstaedter Landstrasse 1, Munich, 85764, Neuherberg, Germany. r.stark@helmholtz-muenchen.de.

C Teuner (C)

Institute of Health Economics and Health Care Management, Helmholtz Zentrum München - German Research Center for Environmental Health, Ingolstaedter Landstrasse 1, Munich, 85764, Neuherberg, Germany.

R Leidl (R)

Institute of Health Economics and Health Care Management, Helmholtz Zentrum München - German Research Center for Environmental Health, Ingolstaedter Landstrasse 1, Munich, 85764, Neuherberg, Germany.

B Lennerz (B)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.
Division of Pediatric Endocrinology, Department of Medicine, Boston Children's Hospital, Boston, MA, USA.

S Brandt (S)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.

J von Schnurbein (J)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.

A Moss (A)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.

E Bollow (E)

Institute for Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany.

E Sergeyev (E)

Hospital for Children and Adolescents, Department of Women and Child Health, University of Leipzig, Leipzig, Germany.

Y Mühlig (Y)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.

S Wiegand (S)

Ambulatory Obesity Center, Charité University Hospital Berlin, Berlin, Germany.

R W Holl (RW)

Institute for Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany.

T Reinehr (T)

Vestische Children's Hospital Datteln, University Witten/Herdecke, Witten, Germany.

W Kiess (W)

Hospital for Children and Adolescents, Department of Women and Child Health, University of Leipzig, Leipzig, Germany.

A Scherag (A)

Institute of Medical Statistics, Computer and Data Sciences, Jena University Hospital, Jena, Germany.

J Hebebrand (J)

Vestische Children's Hospital Datteln, University Witten/Herdecke, Witten, Germany.

M Wabitsch (M)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.

R Holle (R)

Institute of Health Economics and Health Care Management, Helmholtz Zentrum München - German Research Center for Environmental Health, Ingolstaedter Landstrasse 1, Munich, 85764, Neuherberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH